Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose

JAMA Internal Medicine(2021)10.1001/jamainternmed.2021.3779Source: DataRank Database

Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose is a research paper published in JAMA Internal Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 98 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access98 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 11.42)OA: bronzeTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Jason Kwah ORCID,Cosby A. Stone ORCID,Elizabeth J. Phillips ORCID,Gilbert Ortega ORCID,Aleena Banerji ORCID

Live enrichment

PubMed:34309623 PMC:PMC8314170 OpenAlex:https://openalex.org/W3186013111

NIAID NIH HHS

Grant: K01 AI125631

AHRQ HHS

Grant: K12 HS026395

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 2R01AG043538-06

National Social Life and Aging Project: Wave 4

National Institutes of Health

Grant: 5K24AG068312-03

Meaningful Activities and Alzheimer's Disease and Related Dementias

National Institutes of Health

Grant: 5K23AG065438-05

Loneliness and Social Isolation Among Older Adults with and without Alzheimer's Disease and Related Dementia in the Last Years of Life

National Institutes of Health

Grant: 5R24AG064025-04

U.S. Deprescribing Research Network

National Institutes of Health

Grant: 3R01AG048511-10S1

National Social Life, Health and Aging Project: Baby Boom Cohort Wave 2

National Institutes of Health

Grant: 5K24AG049057-03

Medication changes in hospitalized older adults

National Institutes of Health

Grant: 5R01AG033903-05

NSHAP Wave II Partner Data Collection

National Institutes of Health

Grant: 1R03AG064323-01

Loneliness and Social Isolation among Older Adults in the Last Years of LIfe

National Institutes of Health

Grant: 5K01AI125631-04

The Clinical and Economic Impact of Penicillin Allergy

National Institutes of Health

Grant: 5P30AG044281-02

UCSF Older Americans Independence Center

National Institutes of Health

Grant: 5F32AG021847-03

Age-related Individual Differences in Executive Control

National Institutes of Health

Grant: 1R01AG057751-01A1

Prognostic calculators for patients with Alzheimers disease and related dementias

FWCI

11.42

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronze

journalhttps://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2782348/jamainternal_krantz_2021_ld_210043_1635441105.9779.pdf

publisherhttps://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2782348/jamainternal_krantz_2021_ld_210043_1635441105.9779.pdf

journalhttps://doi.org/10.1001/jamainternmed.2021.3779

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34309623

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8314170

Fields of Study

Food Allergy and Anaphylaxis ResearchDrug-Induced Adverse ReactionsSARS-CoV-2 and COVID-19 Research0303 health sciences03 medical and health sciences2019-nCoV Vaccine mRNA-1273AdultAgedBNT162 VaccineCOVID-19 VaccinesFemaleHumansMaleMiddle AgedRetrospective StudiesTime Factors

MeSH Terms

COVID-19 VaccinesBNT162 Vaccine2019-nCoV Vaccine mRNA-1273AdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesTime Factors

Keywords

MedicineCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInternal medicineAdultMaleCOVID-19 VaccinesTime FactorsMiddle AgedHumansFemaleBNT162 Vaccine2019-nCoV Vaccine mRNA-1273AgedRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being